dicarbethoxydihydrocollidine has been researched along with Autoimmune Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, Z; Chen, X; Fang, J; Friedman, S; Gershwin, ME; Guo, C; Ma, X; Miao, Q; Peng, Y; Qiu, D; Shen, L; Tang, R; Wang, Q; Xu, J; Yang, F; Zhang, H; Zhong, W | 1 |
1 other study(ies) available for dicarbethoxydihydrocollidine and Autoimmune Disease
| Article | Year |
|---|---|
Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease.
Topics: Animals; Autoimmune Diseases; Cell Line; Cholestasis, Intrahepatic; Extracellular Matrix Proteins; Gene Expression Regulation; Genetic Therapy; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Liver Diseases; Mice; Mice, Knockout; Pyridines; Smad3 Protein; Transforming Growth Factor beta | 2015 |